Literature DB >> 4063587

The effect of chronic haloperidol treatment on some cardiovascular parameters in cats.

G A Bentley, I W Copeland.   

Abstract

Blood pressure, heart rate and evoked cardiovascular reflexes were examined in cats following chronic treatment with haloperidol, at a dose of 1 mg kg-1 per day, orally for 23 days. Five days after the final dose the animals were anaesthetized and tested for their reaction to various cardiovascular stimuli and to a number of agonist and antagonist drugs, given both intravenously and into the vertebral artery. It was found that treatment with haloperidol caused hypertension in the cats, as well as a potentiation of the pressor response to bilateral carotid occlusion. The response to 30 degrees head-up tilting was also altered so that in treated cats, the blood pressure returned to normal more rapidly during the tilt. There was no difference in the heart rate of the two groups of cats, nor in the pressor response to intravenous noradrenaline or angiotensin II or to afferent brachial nerve stimulation, nor was the depressor action of bradykinin altered. Hexamethonium reduced the blood pressure in both control and treated cats to approximately the same level. Blood O2, CO2, pH and bicarbonate levels were also unaltered by the treatment, as was plasma renin activity. Of the drugs given into the vertebral artery, only noradrenaline, prazosin, ketanserin and haloperidol caused a significantly greater fall in blood pressure in treated than in control cats, while clonidine and St91 were equally effective in both groups. These results suggest that haloperidol treatment has caused a greater modulation of central alpha 1- than of alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063587      PMCID: PMC1916745          DOI: 10.1111/j.1476-5381.1985.tb08953.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.

Authors:  R Dunstan; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

2.  Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.

Authors:  P Muller; P Seeman
Journal:  Life Sci       Date:  1977-12-15       Impact factor: 5.037

3.  R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.

Authors:  N E Andén; C Gomes; B Persson; G Trolin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

4.  Adaptational phenomena in neuroleptic treatment.

Authors:  I M Nielsen; A V Christensen; J Hyttel
Journal:  Adv Biochem Psychopharmacol       Date:  1978

5.  The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.

Authors:  R Dunstan; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

6.  Central effects of sympathomimetic amines on the blood pressure.

Authors:  A Philippu; H Przuntek; G Heyd; A Burger
Journal:  Eur J Pharmacol       Date:  1971-07       Impact factor: 4.432

7.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

8.  Effects of chronic chlorpromazine administration upon the blood pressure responses to autonomic drugs in conscious dogs.

Authors:  W J Lang; M L Brown; S Gershon; I Sletten; B Korol
Journal:  Arch Int Pharmacodyn Ther       Date:  1966-08

9.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

10.  The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.

Authors:  R Dunstan; D M Jackson
Journal:  Clin Exp Pharmacol Physiol       Date:  1977 Mar-Apr       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.